| Michelle Nicole Montalvo, CNM | |
|
2671 Highway 70, Manasquan, NJ 08736-2605 | |
| (732) 528-6999 | |
| (732) 528-3397 |
| Full Name | Michelle Nicole Montalvo |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 2671 Highway 70, Manasquan, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871259697 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 25ME00077300 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michelle Nicole Montalvo, CNM 2671 Highway 70, Manasquan, NJ 08736-2605 Ph: (732) 528-6999 | Michelle Nicole Montalvo, CNM 2671 Highway 70, Manasquan, NJ 08736-2605 Ph: (732) 528-6999 |
News Archive
Northwestern Medicine recently launched a multidisciplinary center dedicated to the comprehensive treatment of patients battling Huntington's disease. The new center will focus on both patient care and research of the inherited disease that causes the progressive breakdown of nerve cells in the brain.
Paratek Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has designated the Company's lead antibiotic candidate, omadacycline (formerly known as PTK 0796), as a Qualified Infectious Disease Product (QIDP) for both intravenous (IV) and oral formulations in the treatment of acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP).
The fundamental process of information transfer from neuron to neuron occurs through a relay of electrical and chemical signaling at the synapse, the junction between neurons. Electrical signals, called action potentials, cause voltage-gated calcium channels on the presynaptic neuron to open.
Even when their tumors are shrinking in response to therapy, some non-small cell lung cancer (NSCLC) patients have a scattering of cancer cells that are undeterred by the drug, causing the tumor to resume its growth, Dana-Farber Cancer Institute and Massachusetts General Hospital (MGH) Cancer Center scientists report in the January issue of Cancer Cell.
› Verified 2 days ago